Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (46)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Misu, K.-i.
Right arrow Articles by Sobue, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Misu, K.-i.
Right arrow Articles by Sobue, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 122, No. 10, 1951-1962, October 1999
© 1999 Oxford University Press

Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan

Clinicopathological and genetic features

Ken-ichiro Misu1, Naoki Hattori1, Masaaki Nagamatsu1, Shu-ichi Ikeda2, Yukio Ando3, Masamitsu Nakazato4, Yo-ichi Takei2, Norinao Hanyu5, Yasuomi Usui6, Fumiaki Tanaka1, Toshihide Harada7, Akira Inukai1, Yoshio Hashizume8 and Gen Sobue1

1 Department of Neurology, Nagoya University School of Medicine, Nagoya, 2 Department of Medicine (Neurology), Shinshu University School of Medicine, Matsumoto, 3 First Department of Internal Medicine, Kumamoto University School of Medicine, Kumamoto, 4 Third Department of Internal Medicine, Miyazaki Medical College, Miyazaki, 5 Department of Neurology, Nagano Red Cross Hospital, Nagano, Okazaki Municipal Hospital, 6 Okazaki, 7 Third Department of Internal Medicine, Hiroshima University School of Medicine, Hiroshima and 8 Institute for Medical Science of Aging, Aichi Medical University, Aichi, Japan

Correspondence to: Gen Sobue, MD, Department of Neurology, Nagoya University School of Medicine, Tsurumai, Nagoya, 466-8550 Japan E-mail: sobueg{at}tsuru.med.nagoya-u.ac.jp

Clinicopathological and genetic features were assessed on 35 Japanese families affected by late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy, FAP TTR Met30) whose siblings were unrelated to endemic Japanese foci. In these patients (50 years or older), the most common initial symptom was paraesthesias in the legs. Autonomic symptoms were generally mild and did not seriously affect daily activities. The male-to-female ratio was extremely high (10.7 : 1). A family history was evident in only 11 out of 35 families, and other patients were apparently sporadic. The rate of penetrance was very low. Symptomatic siblings of familial cases showed a late age of onset, male preponderance and clinical features similar to those of the probands. Asymptomatic carriers, predominantly female, were detected relatively late in life. The geographical distribution of these late-onset, FAP TTR Met30 cases was scattered throughout Japan. In three autopsy cases and 20 sural nerve biopsy specimens, neurons in sympathetic and sensory ganglia were relatively preserved. Amyloid deposition was seen in the peripheral nervous system, particularly in the sympathetic ganglia, dorsal root ganglia and proximal nerve trunks such as sciatic nerve. These abnormalities were milder than those seen in typical early-onset FAP TTR Met30, as observed in two Japanese endemic foci of this disease. While axonal degeneration was prominent in myelinated fibres, resulting in severe fibre loss, unmyelinated fibres were relatively preserved. Our cases of late-onset FAP TTR Met30 showed features distinct from those of typical early-onset FAP TTR Met30 that occurred in the two Japanese endemic foci. Factors responsible for clinicopathological differences between these two forms of FAP TTR Met30 need to be identified.

transthyretin Met30-associated familial amyloid polyneuropathy; transthyretin; clinicopathological study; genetic study; late onset

FAP TTR Met30 = transthyretin Met30-associated familial amyloid polyneuropathy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
S.-i. Ikeda
Is familial amyloid polyneuropathy rare?: DNA testing is changing the concept of this disease
Neurology, August 14, 2007; 69(7): 627 - 628.
[Full Text] [PDF]


Home page
NeurologyHome page
V. Plante-Bordeneuve, A. Ferreira, T. Lalu, C. Zaros, C. Lacroix, D. Adams, and G. Said
Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP)
Neurology, August 14, 2007; 69(7): 693 - 698.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
Y. Oki, H. Koike, M. Iijima, K. Mori, N. Hattori, M. Katsuno, T. Nakamura, M. Hirayama, F. Tanaka, M. Shiraishi, et al.
Ataxic vs painful form of paraneoplastic neuropathy
Neurology, August 7, 2007; 69(6): 564 - 572.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
H Koike, M Hirayama, M Yamamoto, H Ito, N Hattori, F Umehara, K Arimura, S Ikeda, Y Ando, M Nakazato, et al.
Age associated axonal features in HNPP with 17p11.2 deletion in Japan
J. Neurol. Neurosurg. Psychiatry, August 1, 2005; 76(8): 1109 - 1114.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H. Koike, K. Misu, M. Sugiura, M. Iijima, K. Mori, M. Yamamoto, N. Hattori, E. Mukai, Y. Ando, S. Ikeda, et al.
Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy
Neurology, July 13, 2004; 63(1): 129 - 138.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
H Ohmori, Y Ando, Y Makita, Y Onouchi, T Nakajima, M J M Saraiva, H Terazaki, O Suhr, G Sobue, M Nakamura, et al.
Common origin of the Val30Met mutation responsible for the amyloidogenic transthyretin type of familial amyloidotic polyneuropathy
J. Med. Genet., April 1, 2004; 41(4): e51 - e51.
[Full Text] [PDF]


Home page
J. Med. Genet.Home page
V Plante-Bordeneuve, J Carayol, A Ferreira, D Adams, F Clerget-Darpoux, M Misrahi, G Said, and C Bonaiti-Pellie
Genetic study of transthyretin amyloid neuropathies: carrier risks among French and Portuguese families
J. Med. Genet., November 1, 2003; 40(11): e120 - 120.
[Full Text] [PDF]


Home page
BrainHome page
N. Hattori, M. Yamamoto, T. Yoshihara, H. Koike, M. Nakagawa, H. Yoshikawa, A. Ohnishi, K. Hayasaka, O. Onodera, M. Baba, et al.
Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients
Brain, January 1, 2003; 126(1): 134 - 151.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
H. Koike, K.-i. Misu, S.-i. Ikeda, Y. Ando, M. Nakazato, E. Ando, M. Yamamoto, N. Hattori, G. Sobue, and for the Study Group for Hereditary Neuropathy in J
Type I (Transthyretin Met30) Familial Amyloid Polyneuropathy in Japan: Early- vs Late-Onset Form
Arch Neurol, November 1, 2002; 59(11): 1771 - 1776.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S.-i. Ikeda, M. Nakazato, Y. Ando, and G. Sobue
Familial transthyretin-type amyloid polyneuropathy in Japan: Clinical and genetic heterogeneity
Neurology, April 9, 2002; 58(7): 1001 - 1007.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Jiang, J. N. Buxbaum, and J. W. Kelly
The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis
PNAS, December 18, 2001; 98(26): 14943 - 14948.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. T. White and J. W. Kelly
Support for the multigenic hypothesis of amyloidosis: The binding stoichiometry of retinol-binding protein, vitamin A, and thyroid hormone influences transthyretin amyloidogenicity invitro
PNAS, October 25, 2001; (2001) 241406698.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
H Koike, K Misu, N Hattori, S Ito, M Ichimura, H Ito, M Hirayama, M Nagamatsu, I Sasaki, and G Sobue
Postgastrectomy polyneuropathy with thiamine deficiency
J. Neurol. Neurosurg. Psychiatry, September 1, 2001; 71(3): 357 - 362.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H. Koike, K. Mori, K. Misu, N. Hattori, H. Ito, M. Hirayama, and G. Sobue
Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status
Neurology, June 26, 2001; 56(12): 1727 - 1732.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K Misu, T Yoshihara, Y Shikama, E Awaki, M Yamamoto, N Hattori, M Hirayama, T Takegami, K Nakashima, and G Sobue
An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val)
J. Neurol. Neurosurg. Psychiatry, December 1, 2000; 69(6): 806 - 811.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. Misu, N. Hattori, Y. Ando, S. Ikeda, and G. Sobue
Anticipation in early- but not late-onset familial amyloid polyneuropathy (TTR Met 30) in Japan
Neurology, August 8, 2000; 55(3): 451 - 452.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. T. White and J. W. Kelly
Support for the multigenic hypothesis of amyloidosis: The binding stoichiometry of retinol-binding protein, vitamin A, and thyroid hormone influences transthyretin amyloidogenicity invitro
PNAS, November 6, 2001; 98(23): 13019 - 13024.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.